ERYTHROMYCIN ETHYLSUCCINATE
- Product NDC
- 52536-130
- 11-digit product format
- 525360130
- Labeler code
- 52536
- Product ID
- 52536-130_240e9111-2531-403a-bbd3-161d87185b1e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin Ethylsuccinate
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Wilshire Pharmaceuticals
- Application
- NDA050207
- Marketing category
- NDA
- Marketing start
- 2019-03-25
- Substance
- ERYTHROMYCIN ETHYLSUCCINATE
- Active strength
- 400 mg/5mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ERYTHROMYCIN ETHYLSUCCINATE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERYTHROMYCIN ETHYLSUCCINATE | 400 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1014KSJ86F |
| Rxcui | 686400, 686418 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52536-130-13 | ERYTHROMYCIN ETHYLSUCCINATE | 100 mL in 1 BOTTLE | SUSPENSION | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52536-130 | ERYTHROMYCIN ETHYLSUCCINATE SUSPENSION [WILSHIRE PHARMACEUTICALS] | 3 | Current NDC, Legacy NDC, 1 package rows | 20200925_86d6353c-2b58-4219-b31d-fb5b97789094.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52536-130-13 | 52536013013 | 100 mL in 1 BOTTLE (52536-130-13) | 100 ml | 2019-03-25 | 0000-00-00 | No | No | Current |